Showing 1 to 3 of 3 results


Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions
Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.
Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions
Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.
Progress
48% Bias Score


Bayer Extends CEO's Contract Amidst Restructuring
Bayer CEO Bill Anderson's contract is extended by three years until March 2028, following a restructuring that has eliminated 11,000 jobs and aims for €2 billion in cost savings by 2026, to address legal challenges stemming from the Monsanto acquisition.
Bayer Extends CEO's Contract Amidst Restructuring
Bayer CEO Bill Anderson's contract is extended by three years until March 2028, following a restructuring that has eliminated 11,000 jobs and aims for €2 billion in cost savings by 2026, to address legal challenges stemming from the Monsanto acquisition.
Progress
44% Bias Score

Glyphosate Cancer Study: Bayer Challenges Ramazzini Institute Findings
The Ramazzini Institute's study linked glyphosate exposure to increased cancer rates in lab rats, prompting Bayer's criticism over inconsistencies with control groups and a lack of dose-response correlation; the study's findings align with the WHO's 2015 classification of glyphosate as "probably car...

Glyphosate Cancer Study: Bayer Challenges Ramazzini Institute Findings
The Ramazzini Institute's study linked glyphosate exposure to increased cancer rates in lab rats, prompting Bayer's criticism over inconsistencies with control groups and a lack of dose-response correlation; the study's findings align with the WHO's 2015 classification of glyphosate as "probably car...
Progress
52% Bias Score
Showing 1 to 3 of 3 results